Finance

Lists
KPRX:NASDAQ
Kiora Pharmaceuticals Inc
$2.34
-1.68%
(-0.040) 1D
Oct 20, 3:54:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KPRX...
Open
$2.38
High
$2.41
Low
$2.32
Mkt. cap
10.35M
Avg. vol.
14.13K
Volume
16.78K
52-wk high
$2.91
52-wk low
$1.76
EPS
-$2.47
Beta
-0.22
Shares outstanding
4.42M
No. of employees
13
Open
$2.38
High
$2.41
Low
$2.32
Mkt. cap
10.35M
Avg. vol.
14.13K
Volume
16.78K
52-wk high
$2.91
52-wk low
$1.76
EPS
-$2.47
Beta
-0.22
Shares outstanding
4.42M
No. of employees
13
News stories
From web sources and news partners
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersEncinitas, California, United States
SectorPharmaceutical industry
Websitekiorapharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to KPRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for KPRX in the last 3 months
Highest
Current $2.34
$12.00 (+412.82%)
Average
$12.00 (+412.82%)
Lowest
$12.00 (+412.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Okunewitch
Maxim Group
Buy
Maintained
$12.00
+412.8%
08/20/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
1.07M
1.17M
890.50K
740.85K
Cost of revenue
1.07M
1.17M
890.50K
740.85K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.44M
1.46M
1.61M
1.38M
Operating expense
1.44M
1.46M
1.61M
1.38M
Total operating expenses
2.52M
2.63M
2.50M
2.12M
Operating income
-2.52M
-2.63M
-2.50M
-2.12M
Other non operating income
-23.71K
173.24K
-47.13K
-11.47K
EBT including unusual items
-616.32K
-7.17M
-2.42M
-2.08M
EBT excluding unusual items
-2.34M
-2.49M
-2.41M
-1.99M
Income tax expense
-643.13K
-649.97K
-
-
Effective tax rate
104.35%
9.07%
-
-
Other operating expenses
-
-
-
-
Net income
26.81K
-6.52M
-2.42M
-2.08M
Net profit margin
-
-
-
-
Earnings per share
0.01
-
-
-
Interest and investment income
201.82K
190.31K
139.34K
146.23K
Interest expense
-
-19.96K
-
-
Net interest expenses
201.82K
170.35K
139.34K
146.23K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.50M
-2.62M
-2.49M
-2.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps